Avadel Pharma (AVDL) Earnings
|
Expand Research on AVDL
| Next EPS Date | 5/6/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -40.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +14.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/6/24 | Q124 | N/A | -$0.25 | N/A | N/A | $26.66M | N/A | N/A | N/A | ||
| 3/4/24 | Q423 | -$0.32 | -$0.28 | -$0.04 | $19.45M | $18.21M | N/A |  | | Details | |
| 11/8/23 | Q323 | -$0.41 | -$0.38 | -$0.03 | $7.01M | $5.12M | N/A | | | Details | |
| 8/9/23 | Q223 | -$0.83 | -$0.36 | -$0.47 | N/A | $524K | N/A | | | Details | |
| 5/8/23 | Q123 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/20/23 | Q422 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/7/23 | Q422 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A |
